Diabetes Monitor - Information, education, and support for people with diabetes
Home > Other > Press Releases > Press Release:for Safety, Nhlbi Changes Intensive Blood Sugar Treatment Strategy In Clinical Trial Of Diabetes And Cardiovascular Disease

Press Release:for Safety, Nhlbi Changes Intensive Blood Sugar Treatment Strategy In Clinical Trial Of Diabetes And Cardiovascular Disease

Publication Date: 11/18/2007

Conclusions

 

  • Aggressive therapy of Type 2 diabetes is worthwhile.

  •  

  • Combinations of medications and insulin can produce control when monotherapy fails.

Previous slide Next slide Back to first slide View graphic version


Advertisement